These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1615121)

  • 1. Pavlovian conditioning of L-dopa induced movement.
    Carey RJ
    Psychopharmacology (Berl); 1992; 107(2-3):203-10. PubMed ID: 1615121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pavlovian conditioning between co-administered drugs: elicitation of an apomorphine-induced antiparkinsonian response by scopolamine.
    Carey RJ
    Psychopharmacology (Berl); 1991; 104(4):463-9. PubMed ID: 1780415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
    Fenu S; Pinna A; Ongini E; Morelli M
    Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
    Trugman JM; James CL; Wooten GF
    Brain; 1991 Jun; 114 ( Pt 3)():1429-40. PubMed ID: 1829645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
    Blunt SB; Jenner P; Marsden CD
    Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
    Carey RJ
    Brain Res; 1991 Dec; 568(1-2):205-14. PubMed ID: 1814568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A; Fenu S; Morelli M
    Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparkinsonian effects of caffeine depend upon pavlovian drug conditioning processes.
    Carey RJ
    Brain Res; 1990 Jun; 518(1-2):186-92. PubMed ID: 2117987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methyltyrosine blocks the expression of rotation classically conditioned with apomorphine.
    Silverman PB
    Pharmacol Biochem Behav; 1991 Aug; 39(4):1033-5. PubMed ID: 1684868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.
    Pinheiro-Carrera M; Tomaz C; Huston JP; Dai H; Carey RJ
    Life Sci; 1994; 55(13):991-7. PubMed ID: 8084215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone reverses L-dopa induced overstimulation effects in a Parkinson's disease animal model analogue.
    Carey RJ
    Life Sci; 1991; 48(13):1303-8. PubMed ID: 1900558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors.
    Criswell HE; Mueller RA; Breese GR
    Neuropsychopharmacology; 1992 Sep; 7(2):95-103. PubMed ID: 1418306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.
    Taylor JL; Bishop C; Ullrich T; Rice KC; Walker PD
    Neuropharmacology; 2006 May; 50(6):761-8. PubMed ID: 16434065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
    Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.